Biblio
KAP1 stabilizes MYCN mRNA and promotes neuroblastoma tumorigenicity by protecting the RNA mA reader YTHDC1 protein degradation. J Exp Clin Cancer Res. 2024;43(1):141.
. Targeting ARHGEF12 promotes neuroblastoma differentiation, MYCN degradation, and reduces tumorigenicity. Cell Oncol (Dordr). 2022.
Modeling leukemia with pediatric acute leukemia patient-derived iPSCs. Stem Cell Res. 2021;54:102404.
The function of a heterozygous p53 mutation in a Li-Fraumeni syndrome patient. PLoS One. 2020;15(6):e0234262.